WPW
AGN

Waldron Private Wealth’s Allergan plc AGN Stock Holding History

Waldron Private Wealth’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,463
Closed -$348K – 220
2017
Q1 		$348K Buy
+1,463
New +$341K 0.09% 149
2015
Q4 		– Sell
-1,485
Closed -$403K – 182
2015
Q3 		$403K Buy
1,485
+70
+5% +$21.5K 0.17% 57
2015
Q2 		$429K Buy
1,415
+71
+5% +$21.2K 0.17% 50
2015
Q1 		$400K Buy
1,344
+200
+17% +$57K 0.16% 52
2014
Q4 		$294K Hold
1,144
– – 0.12% 75
2014
Q3 		$276K Hold
1,144
– – 0.13% 72
2014
Q2 		$255K Hold
1,144
– – 0.12% 92
2014
Q1 		$235K Buy
+1,144
New +$227K 0.11% 100

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Waldron Private Wealth's AGN Position: Q2 2017 in Review

Waldron Private Wealth sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 1,463 shares — an estimated $348K sold.

Waldron Private Wealth first reported a position in AGN in Q1 2014 and held it in 8 quarters. The position peaked at $429K in Q2 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Waldron Private Wealth reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Waldron Private Wealth sold 1,463 Allergan plc shares in Q2 2017, an estimated $348K.
  • Waldron Private Wealth first reported a position in Allergan plc in Q1 2014 and held it in 8 quarters.
  • Waldron Private Wealth's Allergan plc position peaked at $429K in Q2 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Waldron Private Wealth's 13F filing for Q2 2017, filed 14 Aug 2017.